Headquartered within steps of the USPTO with an affiliate office in Tokyo, Oblon is one of the largest law firms in the United States focused exclusively on intellectual property law.
1968
Norman Oblon with Stanley Fisher and Marvin Spivak launched what was to become Oblon, McClelland, Maier & Neustadt, LLP, one of the nation's leading full-service intellectual property law firms.
Outside the US, we service companies based in Japan, France, Germany, Italy, Saudi Arabia, and farther corners of the world. Our culturally aware attorneys speak many languages, including Japanese, French, German, Mandarin, Korean, Russian, Arabic, Farsi, Chinese.
Oblon's professionals provide industry-leading IP legal services to many of the world's most admired innovators and brands.
From the minute you walk through our doors, you'll become a valuable part of a team that fosters a culture of innovation, client service and collegiality.
The United States Patent and Trademark Office (USPTO) issued final rules implementing the inventor's oath or declaration provisions of the America Invents Act (AIA) on August 14, 2012.
January 31, 2023
November 15, 2022
October 4 and 6, 2022
Brian T. Chung, Ph.D. is a technical advisor in the firm’s Electrical and Mechanical Practice Group focusing on patent preparation and prosecution for domestic and international clients. He is experienced in medical imaging, micro- and nano-device fabrication, and optoelectronics.
Before joining Oblon, he gained exposure drafting patent applications through Stanford University. He also has industry experience working at an indoor lighting startup and interning with the bioelectronics group at Forschungzentrum Jülich in Germany.
Dr. Chung completed his doctoral degree in bioengineering at the University of California San Francisco / Berkeley, where he developed new imaging methods using hyperpolarized 13C MRI for first-in-human brain metabolism studies.
He is skilled in clean room techniques and NMR spectroscopy; has investigated modalities such as positron emission tomography (PET) and optical coherence tomography (OCT) as well as retinal prosthetic systems; and was a professional contributor to the annual Hyperpolarized MRI Technology Resource Center development workshop hosted in San Francisco.
Chung, B.T.; Chen, H.Y.; Gordon, J.; Mammoli, D.; Sriram, R.; Autry, A.W.; LePage, L.M.; Chaumeil, M.M.; Shin, P.; Slater, J.; Tan, C.T.; Suszczynski, C.; Chang, S.; Li, Y.; Bok, R.A.; Ronen, S.M.; Larson, P.; Kurhanewicz, J.; Vigneron, D.B. “First Hyperpolarized [2-13C]Pyruvate MR Studies of Human Brain Metabolism.” J. Magn. Reson., 2019, 309, 106617.
Autry A.; Chung B.; Chen H.Y.; Gordon J.; Lafontaine M.; Chang S.; Villanueva-Meyer J.; Larson P.; Vigneron D.; Li Y. “CBMT-36. Initial Experience With Hyperpolarized [2-13C]Pyruvate MR Imaging in Patients with IDH-Mutant Glioma.” Neuro Oncol., 2019, 21(Suppl 6):vi41.
Mammoli D.; Gordon J.; Autry A.; Larson P.E.Z.; Li Y.; Chen H.Y.; Chung B.; Shin P.; Van Criekinge M.; Carvajal L.; Slater J.B.; Bok R.; Crane J.; Xu D.; Chang S.; Vigneron D.B. “Kinetic Modeling of Hyperpolarized Carbon-13 Pyruvate Metabolism in the Human Brain.” IEEE Trans Med Imaging, 2020, 39(2):320-327.